ABDUL KHAN: Open Payments
NPI 1053349480 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,779 in 83 payments from 21 companies in 2025. Trend: 2023 $2,198 · 2024 $2,692 · 2025 $1,779
Food & beverage: $1,779
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $382 |
| Novo Nordisk Inc | 12 | $235 |
| AstraZeneca Pharmaceuticals LP | 9 | $228 |
| Lilly USA, LLC | 10 | $227 |
| Exact Sciences Corporation | 6 | $145 |
| ABBVIE INC. | 4 | $96 |
| Kowa Pharmaceuticals America, Inc. | 3 | $58 |
| Dexcom, Inc. | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
Products named: TRELEGY ELLIPTA, MOUNJARO, The Cologuard Plus Collection Kit, Wegovy, FARXIGA, AIRSUPRA, ZORYVE, Dexcom G6 Transmitter.
Industry payments across PA — which companies pay providers there.
